Home/Filings/4/0001628908-19-000008
4//SEC Filing

Peterson Thomas III 4

Accession 0001628908-19-000008

CIK 0001628908other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 4:12 PM ET

Size

5.7 KB

Accession

0001628908-19-000008

Insider Transaction Report

Form 4
Period: 2019-03-01
Peterson Thomas III
Chief Operating Officer
Transactions
  • Award

    Leveraged Restricted Stock Unit

    2019-03-01+85,59485,594 total
    Exercise: $0.00Class A Common Stock (85,594 underlying)
Footnotes (3)
  • [F1]Each leveraged stock unit ("LSU") represents the contingent right to receive, upon vesting, between 0% and 200% of one share of the Issuer's Class A common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the LSUs, if any, is based on the cumulative performance of the Issuer's Class A common stock.
  • [F2]These LSUs vest on March 2, 2022
  • [F3]These LSUs do not expire

Issuer

Evolent Health, Inc.

CIK 0001628908

Entity typeother

Related Parties

1
  • filerCIK 0001643498

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:12 PM ET
Size
5.7 KB